We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Search results
From Proteopedia
You searched for Belli,_B.A.
There is no page with the exact title "Belli,_B.A.". The search results for "Belli,_B.A." are displayed below. You can create a page titled Belli,_B.A. (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- User:Olivier Belli (219 bytes)
1: * Full Real Name: Olivier Belli
5: * Institution (NO ABBREVIATIONS): European School of Biotechnology
7: * City, State/Province, Country: Strasbourg, France - Category:Belli, B A (41 bytes)
1: List of pages with the keyword Belli, B A - Category:Belli BA (39 bytes)
1: List of pages with the keyword Belli BA - Category:Belli, R (39 bytes)
1: List of pages with the keyword Belli, R - Category:Belli R (38 bytes)
1: List of pages with the keyword Belli R
Page text matches
- 1ysg (6,058 bytes)
2: ...ic Protein Bcl-xL in Complex with "SAR by NMR" Ligands==
3: ...uctureSection load='1ysg' size='340' side='right'caption='[[1ysg]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=1YSG FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1ysi (6,057 bytes)
2: ...l-xL in complex with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='1ysi' size='340' side='right'caption='[[1ysi]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=1YSI FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1ysn (6,070 bytes)
2: ...cl-xL complexed with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='1ysn' size='340' side='right'caption='[[1ysn]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=1YSN FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1ysw (6,413 bytes)
2: ...Bcl-2 complexed with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='1ysw' size='340' side='right'caption='[[1ysw]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=1YSW FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1ysx (6,366 bytes)
2: ... an anti-apoptotic ligand directed against Bcl-xL and Bcl-2==
3: ...uctureSection load='1ysx' size='340' side='right'caption='[[1ysx]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=1YSX FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 2o1y (5,156 bytes)
2: ...l-xL in complex with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='2o1y' size='340' side='right'caption='[[2o1y]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=2O1Y FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 2o21 (5,499 bytes)
2: ...cl-2 in complex with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='2o21' size='340' side='right'caption='[[2o21]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=2O21 FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 2o22 (5,495 bytes)
2: ...cl-2 in complex with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='2o22' size='340' side='right'caption='[[2o22]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=2O22 FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 2o2f (5,501 bytes)
2: ...cl-2 in complex with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='2o2f' size='340' side='right'caption='[[2o2f]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=2O2F FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 2o2m (5,158 bytes)
2: ...l-xL in complex with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='2o2m' size='340' side='right'caption='[[2o2m]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=2O2M FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 2o2n (5,163 bytes)
2: ...l-xL in complex with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='2o2n' size='340' side='right'caption='[[2o2n]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=2O2N FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - User:Olivier Belli (219 bytes)
1: * Full Real Name: Olivier Belli
5: * Institution (NO ABBREVIATIONS): European School of Biotechnology
7: * City, State/Province, Country: Strasbourg, France - Category:Belli, B A (41 bytes)
1: List of pages with the keyword Belli, B A - Category:Belli BA (39 bytes)
1: List of pages with the keyword Belli BA - 6yio (4,213 bytes)
2: ==CRYSTAL STRUCTURE OF FAB RG6292 IN COMPLEX WITH CD25 ECD==
3: ...caption='[[6yio]], [[Resolution|resolution]] 1.83&Aring;' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=6YIO FirstGlance]. <br>
6: ...d><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.83&#8491;</td><... - 7kmg (5,996 bytes)
2: ==LY-CoV555 neutralizing antibody against SARS-CoV-2==
3: ...caption='[[7kmg]], [[Resolution|resolution]] 2.16&Aring;' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=7KMG FirstGlance]. <br>
6: ...d><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.16&#8491;</td><... - 7kmh (6,048 bytes)
2: ==LY-CoV488 neutralizing antibody against SARS-CoV-2==
3: ...caption='[[7kmh]], [[Resolution|resolution]] 1.72&Aring;' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=7KMH FirstGlance]. <br>
6: ...d><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.72&#8491;</td><... - 7kmi (5,999 bytes)
2: ==LY-CoV481 neutralizing antibody against SARS-CoV-2==
3: ...caption='[[7kmi]], [[Resolution|resolution]] 1.73&Aring;' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=7KMI FirstGlance]. <br>
6: ...d><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.73&#8491;</td><... - 7l3n (5,515 bytes)
2: ==SARS-CoV 2 Spike Protein bound to LY-CoV555==
3: ...caption='[[7l3n]], [[Resolution|resolution]] 3.27&Aring;' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=7L3N FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] ... - 7p47 (3,631 bytes)
2: ==Structure of the E3 ligase Smc5/Nse2 in complex with Ubc9-SUMO thioester m...
3: ...caption='[[7p47]], [[Resolution|resolution]] 3.31&Aring;' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=7P47 FirstGlance]. <br>
6: ...d><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.314&#8491;</td>...
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
